Search results for "Secretagogue"

showing 3 items of 3 documents

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

2003

Summary objective Little is known of the usefulness of GH secretagogues (GHSs) in GH-deficient (GHD) adults. The objective of this study was to determine the number of responders to treatment with NN703 in GHD adults. design A multicentre, randomized, double-blind, and placebo-controlled study. patients Ninety-seven GHD adults were included. measurements The GH response before and after 1 week of oral treatment with NN703 (n = 83) or placebo (n = 14) was determined. The first and last dose of NN703 was 3 mg/kg, whereas the dose of NN703 was 1·5 mg/kg/day during the 6 days between the first and last doses. Furthermore, all 97 patients received 1 µg/kg GH-releasing hormone (GHRH) 3 weeks afte…

medicine.medical_specialtyChemotherapybusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPlacebomedicine.diseaseGrowth hormone deficiencyEndocrinologyBlood pressureEndocrinologyOral administrationGrowth hormone secretagogueInternal medicineStatistical significancemedicinebusinessHormoneClinical Endocrinology
researchProduct

Secretory effect of azodisalicylate (azodisal sodium) on the short circuited mucosa of the rat ileum in vitro.

1988

Azodisalicylate (ADS) is one of the newly developed substitutes of sulphasalazine consisting of two molecules of 5-amino-salicylic acid. Azodisalicylate caused diarrhoea in some patients, apparently caused by an antiabsorptive secretagogue action of this compound. The mechanism of this was studied in the short circuited isolated mucosa of the rat ileum. Mucosal addition of ADS increased the potential difference (PD) and short circuit current (Isc) at a concentration of 1.3.10(-4) mol/l (4 mg/dl) with maximal effects at 1.3.10(-3) mol/l (40 mg/dl). Epithelial resistance was only slightly decreased at the higher concentrations of 40 and 100 mg/dl. Serosal ADS had no effect on electrical param…

medicine.medical_specialtySodiumIndomethacinchemistry.chemical_elementIleumIn Vitro TechniquesBiologyEpitheliumMembrane PotentialsChloridesIntestinal mucosaFurosemideIleumInternal medicinemedicineAnimalsSecretionIntestinal MucosaTranscellularMembrane potentialSodiumElectric ConductivityGastroenterologyStimulation ChemicalRatsAminosalicylic AcidsEndocrinologymedicine.anatomical_structureMechanism of actionchemistrySecretagoguemedicine.symptomResearch ArticleGut
researchProduct

Changes in Gastric Mucosal Permeability Induced by Haemorrhagic Shock in the Anaesthetized Rat: - Modulation by Acid

1998

Abstract Gastric mucosal damage induced by haemorrhagic shock in the anaesthetized rat has been evaluated by studying changes in capillary-to-lumen clearance of fluorescein isothiocyanate (FITC)-labelled dextran. Haemorrhagic shock (20 min ischaemia + 20 min reperfusion) induced a significant increase in blood-to-lumen permeability to FITC-dextran of different molecular weight (10 000, 40 000 and 70 000) without modifying the macroscopic integrity of the gastric mucosa. The increase in vascular permeability was dependent on the time of administration of the tracer and was correlated with an elevation of the protein content of the gastric lumen. Intravenous administration of the secretagogue…

Pathologymedicine.medical_specialtyPharmaceutical ScienceVascular permeabilityShock HemorrhagicPharmacologyCapillary Permeabilitychemistry.chemical_compoundGastric mucosaAnimalsMedicineRats WistarFluorescein isothiocyanatePharmacologybusiness.industryDextransHydrogen-Ion ConcentrationRatsPentagastrinDextranmedicine.anatomical_structurechemistryGastric MucosaPermeability (electromagnetism)Shock (circulatory)Secretagoguemedicine.symptombusinessFluorescein-5-isothiocyanatemedicine.drugJournal of Pharmacy and Pharmacology
researchProduct